Legal & General Group
OLMA icon

Legal & General Group’s Olema Pharmaceuticals OLMA Stock Holding History

Legal & General Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Buy
37,540
+5,875
+19% +$78.7K ﹤0.01% 2419
2026
Q1 		$472K Buy
31,665
+11,175
+55% +$249K ﹤0.01% 2367
2025
Q4 		$512K Buy
20,490
+15,068
+278% +$268K ﹤0.01% 2427
2025
Q3 		$53.1K Hold
5,422
– – ﹤0.01% 2720
2025
Q2 		$23.1K Buy
5,422
+1,417
+35% +$6.32K ﹤0.01% 2950
2025
Q1 		$15.1K Sell
4,005
-25,711
-87% -$129K ﹤0.01% 3045
2024
Q4 		$173K Hold
29,716
– – ﹤0.01% 2678
2024
Q3 		$355K Buy
29,716
+307
+1% +$3.92K ﹤0.01% 2569
2024
Q2 		$318K Buy
29,409
+2,115
+8% +$22.9K ﹤0.01% 2580
2024
Q1 		$309K Buy
27,294
+2,761
+11% +$35.6K ﹤0.01% 2598
2023
Q4 		$344K Buy
24,533
+22,106
+911% +$297K ﹤0.01% 2583
2023
Q3 		$30K Sell
2,427
-153
-6% -$1.56K ﹤0.01% 2922
2023
Q2 		$23.3K Buy
+2,580
New +$15.6K ﹤0.01% 3052
2022
Q2 		– Sell
-4,749
Closed -$20K – 3617
2022
Q1 		$20K Sell
4,749
-550
-10% -$3.03K ﹤0.01% 3242
2021
Q4 		$49K Buy
5,299
+3,007
+131% +$62.3K ﹤0.01% 3036
2021
Q3 		$63K Buy
2,292
+1,150
+101% +$31K ﹤0.01% 2927
2021
Q2 		$32K Sell
1,142
-103
-8% -$2.93K ﹤0.01% 3113
2021
Q1 		$41K Buy
+1,245
New +$53.4K ﹤0.01% 2882

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Legal & General Group's OLMA Position: Q2 2026 in Review

Legal & General Group increased its Olema Pharmaceuticals (OLMA) stake by 19% in Q2 2026, buying an estimated $78.7K and bringing the position to 37,540 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #2419.

Legal & General Group first reported a position in OLMA in Q1 2021 and has held it in 18 quarters since. The position peaked at $512K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Legal & General Group held 37,540 shares of Olema Pharmaceuticals worth $470K as of Q2 2026.
  • Legal & General Group bought 5,875 Olema Pharmaceuticals shares in Q2 2026, an estimated $78.7K.
  • Olema Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2419 holding.
  • Legal & General Group first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
  • Legal & General Group's Olema Pharmaceuticals position peaked at $512K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.